France-based bioMérieux has acquired the privately held US company, BioFire Diagnostics Inc for $400 million, consolidating its position as a major player in infectious disease diagnostics.

SAN DIEGO--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced the appointment of Rachel Jones as Chief Commercial Officer. With over 25 ...

MONTREAL, Feb. 25, 2025 /CNW/ - bioMérieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE ® SPOTFIRE ® ...